Clinical Trial Update: Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety and efficacy of ARQ-252 cream in chronic hand eczema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Eczema

Drugs mentioned

• ARQ-252 (ARQ-252)

Snippet

Sponsor: Arcutis Biotherapeutics, Inc. | Conditions: Chronic Hand Eczema | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-04-05